Novartis Oncology
-
Yardley-Based Jubilant Therapeutics Appoints Industry Veteran as New CEO
Jubilant Therapeutics, a Yardley-based biopharmaceutical company focused on cancer and autoimmune disease treatments, has named Daniel J. O’Connor to be its new CEO, writes John…
-
King of Prussia-Based Qlik Prepares for Second IPO with Series of Acquisitions
King of Prussia-based Qlik is preparing to offer another IPO opportunity after it recently boosted its product line through several acquisitions, writes Joseph DiStefano for…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
